Table of Contents Author Guidelines
International Journal of Medicinal Chemistry
Volume 2015, Article ID 430248, 54 pages
http://dx.doi.org/10.1155/2015/430248
Review Article

A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model

1Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI 53201, USA
2Department of Pharmacology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
3Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS 39216, USA
4Department of Anesthesiology, Columbia University, New York, NY 10032, USA
5Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA
6Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI 53201, USA

Received 11 February 2015; Revised 16 June 2015; Accepted 2 July 2015

Academic Editor: Hussein El-Subbagh

Copyright © 2015 Terry Clayton et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [15 citations]

The following is the list of published articles that have cited the current article.

  • Gloria S. Forkuo, Margaret L. Guthrie, Nina Y. Yuan, Amanda N. Nieman, Revathi Kodali, Rajwana Jahan, Michael R. Stephen, Gene T. Yocum, Marco Treven, Michael M. Poe, Guanguan Li, Olivia B. Yu, Benjamin D. Hartzler, Nicolas M. Zahn, Margot Ernst, Charles W. Emala, Douglas C. Stafford, James M. Cook, and Leggy A. Arnold, “ Development of GABA A Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments ,” Molecular Pharmaceutics, 2016. View at Publisher · View at Google Scholar
  • Andrea Cappelli, Maurizio Anzini, Federica Castriconi, Giorgio Grisci, Marco Paolino, Carlo Braile, Salvatore Valenti, Germano Giuliani, Salvatore Vomero, Angela Di Capua, Laura Betti, Gino Giannaccini, Antonio Lucacchini, Carla Ghelardini, Lorenzo Di Cesare Mannelli, Maria Frosini, Lorenzo Ricci, Gianluca Giorgi, Maria Paola Mascia, and Giovanni Biggio, “ Design, Synthesis, and Biological Evaluation of Imidazo[1,5- a ]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors ,” Journal of Medicinal Chemistry, 2016. View at Publisher · View at Google Scholar
  • Michael M. Poe, Kashi Reddy Methuku, Guanguan Li, Ashwini R. Verma, Kelly A. Teske, Douglas C. Stafford, Leggy A. Arnold, Jeffrey W. Cramer, Timothy M. Jones, Rok Cerne, Michael J. Krambis, Jeffrey M. Witkin, Enrique Jambrina, Sabah Rehman, Margot Ernst, James M. Cook, and Jeffrey M. Schkeryantz, “ Synthesis and Characterization of a Novel γ-Aminobutyric Acid Type A (GABA A ) Receptor Ligand That Combines Outstanding Metabolic Stability, Pharmacokinetics, and Anxiolytic Efficacy ,” Journal of Medicinal Chemistry, 2016. View at Publisher · View at Google Scholar
  • Tamara Timić Stamenić, Michael M Poe, Sabah Rehman, Anja Santrač, Branka Divović, Petra Scholze, Margot Ernst, James M Cook, and Miroslav M Savić, “Ester to amide substitution improves selectivity, efficacy and kinetic behavior of a benzodiazepine positive modulator of GABAA receptors containing the α5 subunit.,” European journal of pharmacology, vol. 791, pp. 433–443, 2016. View at Publisher · View at Google Scholar
  • Gloria S. Forkuo, Amanda N. Nieman, Nina Y. Yuan, Revathi Kodali, Olivia B. Yu, Nicolas M. Zahn, Rajwana Jahan, Guanguan Li, Michael Rajesh Stephen, Margaret L. Guthrie, Michael M. Poe, Benjamin D. Hartzler, Ted W. Harris, Gene T. Yocum, Charles W. Emala, Douglas A. Steeber, Douglas C. Stafford, James M. Cook, and Leggy A. Arnold, “ Alleviation of Multiple Asthmatic Pathologic Features with Orally Available and Subtype Selective GABA A Receptor Modulators ,” Molecular Pharmaceutics, 2017. View at Publisher · View at Google Scholar
  • August F Holtyn, V V N Phani Babu Tiruveedhula, Michael Rajesh Stephen, James M Cook, and Elise M Weerts, “Effects of the benzodiazepine GABAA α1-preferring antagonist 3-isopropoxy-β-carboline hydrochloride (3-ISOPBC) on alcohol seeking and self-administration in baboons.,” Drug and alcohol dependence, vol. 170, pp. 25–31, 2017. View at Publisher · View at Google Scholar
  • Rajwana Jahan, Guanguan Li, Olivia B Yu, Gene T Yocum, Charles W Emala, Douglas C Stafford, James M Cook, Leggy A Arnold, Michael Rajesh Stephen, Gloria S Forkuo, Revathi Kodali, Margaret L Guthrie, Amanda N Nieman, Nina Y Yuan, Nicolas M Zahn, and Michael M Poe, “Optimization of substituted imidazobenzodiazepines as novel asthma treatments.,” European journal of medicinal chemistry, vol. 126, pp. 550–560, 2017. View at Publisher · View at Google Scholar
  • Hanns Möhler, and Uwe Rudolph, “Disinhibition, an emerging pharmacology of learning and memory,” F1000Research, vol. 6, 2017. View at Publisher · View at Google Scholar
  • Alshaimaa A. Elgarf, David C. B. Siebert, Friederike Steudle, Angelika Draxler, Guanguan Li, Shengming Huang, James M. Cook, Margot Ernst, and Petra Scholze, “ Different Benzodiazepines Bind with Distinct Binding Modes to GABA A Receptors ,” ACS Chemical Biology, 2018. View at Publisher · View at Google Scholar
  • Gloria S. Forkuo, Amanda N. Nieman, Revathi Kodali, Nicolas M. Zahn, Guanguan Li, M. S. Rashid Roni, Michael Rajesh Stephen, Ted W. Harris, Rajwana Jahan, Margaret L. Guthrie, Olivia B. Yu, Janet L. Fisher, Gene T. Yocum, Charles W. Emala, Douglas A. Steeber, Douglas C. Stafford, James M. Cook, and Leggy A. Arnold, “ A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABA A Receptors in the Lung ,” Molecular Pharmaceutics, 2018. View at Publisher · View at Google Scholar
  • Daniel E. Knutson, Revathi Kodali, Branka Divović, Marco Treven, Michael R. Stephen, Nicolas M. Zahn, Vladimir Dobričić, Alec T. Huber, Matheus A. Meirelles, Ranjit S. Verma, Laurin Wimmer, Christopher Witzigmann, Leggy A. Arnold, Lih-Chu Chiou, Margot Ernst, Marko D. Mihovilovic, Miroslav M. Savić, Werner Sieghart, and James M. Cook, “ Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABA A R) α6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability ,” Journal of Medicinal Chemistry, 2018. View at Publisher · View at Google Scholar
  • A. I. Golovko, M. B. Ivanov, E. S. Golovko, V. B. Dolgo-Saburov, and E. P. Zatsepin, “The Neurochemical Mechanisms of the Pharmacological Activities of Inverse Agonists of the Benzodiazepine Binding Site,” Neurochemical Journal, vol. 12, no. 4, pp. 337–346, 2018. View at Publisher · View at Google Scholar
  • Nina Z. Xu, Margot Ernst, Marco Treven, Rok Cerne, Mark Wakulchik, Xia Li, Timothy M. Jones, Scott D. Gleason, Denise Morrow, Jeffrey M. Schkeryantz, Md. Toufiqur Rahman, Guanguan Li, Michael M. Poe, James M. Cook, and Jeffrey M. Witkin, “Negative allosteric modulation of alpha 5-containing GABAA receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing mice,” Psychopharmacology, 2018. View at Publisher · View at Google Scholar
  • Tija C. Jacob, “Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors,” Frontiers in Molecular Neuroscience, vol. 12, 2019. View at Publisher · View at Google Scholar
  • Laura Kallay, Havva Keskin, Alexandra Ross, Manali Rupji, Olivia A. Moody, Xin Wang, Guanguan Li, Taukir Ahmed, Farjana Rashid, Michael Rajesh Stephen, Kirsten A. Cottrill, T. Austin Nuckols, Maxwell Xu, Deborah E. Martinson, Frank Tranghese, Yanxin Pei, James M. Cook, Jeanne Kowalski, Michael D. Taylor, Andrew Jenkins, Daniel A. Pomeranz Krummel, and Soma Sengupta, “Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death,” Journal of Neuro-Oncology, 2019. View at Publisher · View at Google Scholar